Single-cell Epigenetics of Tau Dementia | Part 2 - Exploring Disease-associated Dynamic Peaks, Functional Variants, eQTLs, and Cellular Subcluster Diversity

By Stuart P. Atkinson

image 0
Condition-dynamic and case-control differentially accessible CREs across human brain cell types. (K) TF enrichment in dynamic peaks per cell type, analyzed using MEME. (L) Bar plot showing the number of differentially accessible CREs per disease across cell types, divided into up-regulated and down-regulated peaks. DA-CREs are identified by P<=1e−3 and |Log2FC| >=1.2. (M) Heatmaps of PiD DA-CREs up-regulated in the PreCG and down-regulated in the Insula, shown for astrocytes (left), oligodendrocytes (middle), and inhibitory neurons (right). Enriched GO terms and KEGG pathways of the genes linked to CREs are displayed at the bottom. (N) Gene network of synaptic plasticity-regulating genes involved in the PiD DA-CREs transition across regions in inhibitory neurons. Genes linked to PiD DA-CREs are highlighted within the red circle. The network is constructed using GeneMANIA 75. DA-CREs: differentially accessible cis-regulatory elements.

Understanding Tauopathies Through Single-cell Epigenetic and Transcriptomic Analyses

Epigenome Technologies Blog brings you part two of a three-part summary of a recent single-cell epigenetics preprint article from researchers led by Jessica E. Rexach (University of California, Los Angeles), who sought to define cell-type-specific cis-regulatory elements (CREs) via chromatin accessibility (snATAC-seq) and gene expression (snRNA-seq) analysis in single nuclei across 6 cell types and 50 subclasses in samples from brain regions with distinct vulnerabilities in Alzheimers disease (AD), Picks disease (PiD), and progressive supranuclear palsy (PSP) patients to understand the regulatory circuitry of non-coding genetic variants underlying risk-associated cell states (Han et al.).

The authors provide a cross-disorder atlas linking gene regulation, chromatin dynamics, and cellular functions across tau-related disorders to highlight disorder-specific glial states of differential resilience. In doing so, they enhance our understanding of disease regulatory circuits by uncovering epigenomic dynamics and mapping genetic variants to their target through CREs, prioritize genes for validation to inform causal mechanisms and therapeutic strategies by identifying molecular targets linked to polygenic disease risk, enhance our understanding of glial contributions to tauopathies at the single-cell level, and underscore the importance of cross-disorder, cell-specific chromatin profiling in brain regions with moderate pathology.

image 1
image 1

Exploring Disease-associated Dynamic Peaks, Functional Variants, eQTLs, and Cellular Subcluster Diversity

image 2
image 2

Can Disease-associated Dynamic Peaks Explain Disease-associated Genetic Variants?

Exploring Massively Parallel Reporter Assay-Validated Functional Variants within Dynamic Peaks

image 3
image 3

Assessing the Enrichment of Single-Nucleus Quantitative Trait Loci in Dynamic Chromatin

image 4
image 4

How Does the Diversity of Cellular Subclusters Change Across Brain Regions?

What Can Paired-Tag from Epigenome Technologies Do for Your Research?

Paired-Tag from Epigenome Technologies generates joint epigenetic and transcriptomic profiles at single-cell resolution and detects histone modifications and RNA transcripts in individual nuclei with comparable efficiency to single-nucleus RNA-seq/ChIP-seq assays while avoiding the need for cell sorting. The implementation of Paired-Tag technology may enable researchers to make significant strides in understanding gene regulation and improving the management of diseases, such as the neurodegenerative tauopathies explored in this exciting preprint.